XML 48 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Non-Controlling Interest in Consolidated Subsidiaries
12 Months Ended
Dec. 31, 2020
IFRS Text Block [Abstract]  
Non-ControllingInterest in Consolidated Subsidiaries

Note 22. Non-Controlling Interest in Consolidated Subsidiaries

An analysis of FEMSA’s non-controlling interest in its consolidated subsidiaries as of December 31, 2020 and 2019 is as follows:

 

 

 

 

 

 

 

 

    

December 31, 

    

December 31, 

 

 

2020

 

2019

Coca-Cola FEMSA

 

Ps.

66,800

 

Ps.

72,649

Other

 

 

2,644

 

 

1,113

 

 

Ps.

69,444

 

Ps.

73,762

 

The changes in the FEMSA’s non-controlling interest were as follows:

 

 

 

 

 

 

 

 

 

 

 

    

2020

    

2019

    

2018

Balance at beginning of the period

 

Ps.

73,762

 

Ps.

78,489

 

Ps.

86,621

Net income of non-controlling interest  

 

 

5,686

 

 

7,349

 

 

9,089

Other comprehensive income (loss):

 

 

(5,793)

 

 

(4,552)

 

 

(4,080)

   Exchange differences on translation of foreign operation

 

 

(5,958)

 

 

(3,833)

 

 

(4,016)

   Remeasurements of the net defined benefits liability

 

 

(169)

 

 

(271)

 

 

155

   Valuation of the effective portion of derivative financial instruments

 

 

334

 

 

(448)

 

 

(219)

Dividends

 

 

(5,524)

 

 

(3,945)

 

 

(3,713)

Share based payment

 

 

(64)

 

 

(12)

 

 

31

Acquisition of Socofar non-controlling interest

 

 

 —

 

 

(3,530)

 

 

 —

Acquisition of Synergy non-controlling interest (see Note 4.1)

 

 

1,298

 

 

 —

 

 

 —

Other acquisitions and remeasurements

 

 

79

 

 

32

 

 

413

(Derecognition) from non-controlling interest

 

 

 —

 

 

 —

 

 

(11,140)

Accounting standard adoption effects (“IFRIC 23 and IFRS 9”)

 

 

 —

 

 

(69)

 

 

(150)

Adoption of IAS 29 for Argentina

 

 

 —

 

 

 —

 

 

1,418

Balance at end of the period

 

Ps.

69,444

 

Ps.

73,762

 

Ps.

78,489

 

Non-controlling interest’s accumulated other comprehensive income is comprised as follows:

 

 

 

 

 

 

 

 

    

 

 

    

 

 

 

 

December 31, 

 

December 31, 

 

 

2020

 

2019

Exchange differences on translation foreign operation

 

Ps.

(6,657)

 

Ps.

(699)

Remeasurements of the net defined benefits liability

 

 

(559)

 

 

(390)

Valuation of the effective portion of derivative financial instruments

 

 

(277)

 

 

(611)

Accumulated other comprehensive income

 

Ps.

(7,493)

 

Ps.

(1,700)

 

Coca-Cola FEMSA shareholders, especially the Coca-Cola Company which hold Series D shares, have some protective rights about investing in or disposing of significant businesses. However, these rights do not limit the continued normal operations of Coca-Cola FEMSA.

Summarized financial information in respect of Coca-Cola FEMSA is set out below:

 

 

 

 

 

 

 

 

    

December 31, 

 

December 31, 

 

 

2020

 

2019

Total current assets

 

Ps.

72,440

 

Ps.

56,796

Total non-current assets

 

 

190,626

 

 

201,043

Total current liabilities

 

 

42,845

 

 

51,010

Total non-current liabilities

 

 

97,764

 

 

77,144

Total revenue

 

Ps.

183,615

 

Ps.

194,471

Consolidated net (loss) income for continuing operations

 

 

10,368

 

 

12,630

Consolidated comprehensive income for continuing operations

 

Ps.

3,050

 

Ps.

5,489

Net cash flow generated from operating activities for continuing operations

 

 

35,147

 

 

31,289

Net cash flow used in investing activities for continuing operations

 

 

(10,508)

 

 

(10,744)

Net cash flow used in financing activities for continuing operations

 

 

417

 

 

(22,794)

 

22.1 Options embedded from past acquisitions

FEMSA Comercio – Health Division entered into option transactions regarding the remaining 40% non-controlling interest not held by FEMSA Comercio – Health Division.

On December 13, 2019, the former controlling shareholders of Socofar exercised their put option to sell the remaining 40% non-controlling interest to FEMSA Comercio – Health Division at the fair value of the interest. As of  December 31, 2019 the Company recognized a loss in the consolidated statements of changes in equity and Socofar has been included 100% in the consolidated statements of financial position.

The former controlling shareholders of Open Market retain a put for their remaining 20% non-controlling interest that can be exercised (i) at any time after the acquisition date upon the occurrence of certain events and (ii) annually from January through April, after the third anniversary of the acquisition date. In any event, the Company through one of its subsidiaries can call the remaining 20% non-controlling interest annually from January through April, after the fifth anniversary of the acquisition date. Both options would be exercisable at the then fair value of the interest and shall remain indefinitely.